Have a question? Give us a call! 800-979-2869
Check out our latest deals!
Nobivac® Canine 1-DAPPvL2
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus-Leptospira Bacterin
U.S. Vet. Lic. No.: 165A
Contents: Nobivac® Canine 1-DAPPvL2 is a modified live virus vaccine which is combined with inactivated Leptospira canicola and L. icterohaemorrhagiae bacterin.
Contains gentamicin as a preservative.
Indications: Nobivac® Canine 1-DAPPvL2 is for the vaccination of healthy dogs against diseases caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus and leptospirosis.
Dosage and Administration: Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended.
Transfer contents of the sterile diluent vial to the Nobivac® Canine 1-DAPPvL2 vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Contraindication(s): Do not vaccinate pregnant bitches.
Precaution(s): Store between 2° and 7°C. Do not freeze.
Use new, non-chemically sterilized, needles and syringes.
Do not mix with other vaccines.
Burn vaccine container and all unused contents.
Caution(s): Vaccinate only healthy, non-parasitized dogs.
The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
The age at which maternal antibodies for canine parvovirus no longer interferes with the development of active immunity and varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.
Antidote(s): Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
Warning(s): For veterinary use only.
For use in dogs only.
Trial Data: Data indicate the development of corneal opacity is not associated with the use of this product.
Pat. Pending (feline enteric coronavirus)
Presentation: 25 x 1 dose vials of Nobivac® Canine 1-DAPPvL2. 25 x 1 mL vials of sterile diluent.
NAC No.: 10470841
Features & Benefits
* High antigenic mass (titer), low passage parvovirus vaccine. * Canine vaccine containing parvovirus type 2b, the most prevalent field strain of parvovirus. * Canine parvovirus type 2b protects against all field strains currently seen. * Overrides maternal antibodies in young puppies. Primary vaccination may begin as early as 6 weeks. Last dose may be given at 12 weeks of age. * No reversion to virulence. * Onderstepoort-type distemper strain, proven efficacious for over 50 years. * Lyophilized L. canicola and L. icterohaemorrhagiae provide broad protection with added stability and convenience.
Indications For the vaccination of healthy dogs against canine distemper, adenovirus type 2, hepatitis, parainfluenza, parvovirus and leptospirosis.